Positive social interactions during the juvenile and adolescent phases of life, in the form of social play behavior, are important for social and cognitive development. However, the neural mechanisms of social play behavior remain incompletely understood. We have previously shown that methylphenidate and atomoxetine, drugs widely used for the treatment of attention-deficit hyperactivity disorder (ADHD), suppress social play in rats through a noradrenergic mechanism of action. Here, we aimed to identify the neural substrates of the play-suppressant effects of these drugs. Methylphenidate is thought to exert its effects on cognition and emotion through limbic corticostriatal systems. Therefore, methylphenidate was infused into prefrontal and orbitofrontal cortical regions as well as into several subcortical limbic areas implicated in social play. Infusion of methylphenidate into the anterior cingulate cortex, infralimbic cortex, basolateral amygdala, and habenula inhibited social play, but not social exploratory behavior or locomotor activity. Consistent with a noradrenergic mechanism of action of methylphenidate, infusion of the noradrenaline reuptake inhibitor atomoxetine into these same regions also reduced social play. Methylphenidate administration into the prelimbic, medial/ventral orbitofrontal, and ventrolateral orbitofrontal cortex, mediodorsal thalamus, or nucleus accumbens shell was ineffective. Our data show that the inhibitory effects of methylphenidate and atomoxetine on social play are mediated through a distributed network of prefrontal and limbic subcortical regions implicated in cognitive control and emotional processes. These findings increase our understanding of the neural underpinnings of this developmentally important social behavior, as well as the mechanism of action of two widely used treatments for ADHD.
Introduction
Social play behavior is a vigorous form of social interaction that is abundantly expressed in the juvenile and adolescent of most mammalian species, including humans. It is thought that social play behavior has an important role in social, cognitive, and emotional development (Fagen, 1981; Panksepp et al., 1984; Špinka et al., 2001 ; Pellis and Pellis, 2009; Graham and Burghardt, 2010; Baarendse et al., 2013; Vanderschuren and Trezza, 2014) . However, our knowledge of the neural mechanisms underlying social play is limited Trezza et al., 2010; Siviy and Panksepp, 2011; Vanderschuren and Trezza, 2014) . Identifying the neural underpinnings of social play will increase our understanding of adaptive behavioral development and of the etiology of childhood and adolescent psychiatric disorders characterized by social impairments, such as autism and attention-deficit/hyperactivity disorder (ADHD).
Pharmacological modulation of social play behavior has revealed that psychomotor stimulants such as amphetamine and methylphenidate profoundly inhibit social play (Beatty et al., 1982 ; Thor and Holloway, 1983; Sutton and Raskin, 1986; Vanderschuren et al., 2008; Achterberg et al., 2014) . Importantly, we have previously shown that methylphenidate and amphetamine inhibit social play through a noradrenergic mechanism of action. Their play-suppressant effect was mimicked by the noradrenaline reuptake inhibitor atomoxetine, but not the dopamine reuptake inhibitor GBR12909, and their effect on social play was blocked by pretreatment with an ␣2-adrenoceptor antagonist, but not a dopamine receptor antagonist Achterberg et al., 2014) . Moreover, combined administration of subeffective doses of methylphenidate and atomoxetine reduced social play behavior , indicating that methylphenidate and atomoxetine inhibit social play behavior through a common, noradrenergic mechanism of action. Interestingly, methylphenidate, amphetamine, and atomoxetine are widely used to treat ADHD (Kutcher et al., 2004; Kratochvil et al., 2006; Feldman and Reiff, 2014) . Therefore, investigating their effects on social behavior in young animals may help to understand their mechanism of action and potential side effects in the treatment of ADHD.
We previously hypothesized that the effects of methylphenidate and atomoxetine on social play were related to enhanced behavioral inhibition because these drugs facilitate several aspects of cognitive control (Chamberlain and Sahakian, 2007; Eagle et al., 2008; Pattij and Vanderschuren, 2008) through prefrontal corticostriatal circuits (Arnsten, 2011; Del Campo et al., 2011) . In addition, these drugs could influence social play behavior by altering its emotional properties (Andersen, 2005; Trezza et al., 2010; Siviy and Panksepp, 2011) . Therefore, to identify the neural sites of action through which methylphenidate reduces social play, we infused this drug into several prefrontal and orbitofrontal regions, the nucleus accumbens shell, mediodorsal thalamus, basolateral amygdala (BLA), and habenula. These regions have been implicated in cognitive and emotional processes (McAlonan et al., 1993; Chudasama et al., 2001; Miller and Cohen, 2001; Baxter and Murray, 2002; Cardinal et al., 2002; Phelps and LeDoux, 2005; Block et al., 2007; Lecourtier and Kelly, 2007; Robbins and Arnsten, 2009; Schoenbaum et al., 2009; Hikosaka, 2010; Morrison and Salzman, 2010; Berridge and Kringelbach, 2013) , including social play ( Siviy and Panksepp, 1985; Panksepp et al., 1994; Schneider and Koch, 2005; Pellis et al., 2006; Bell et al., 2009; Trezza et al., 2011a van Kerkhof et al., 2013a van Kerkhof et al., , 2013b van Kerkhof et al., , 2014 , and receive a well characterized noradrenergic innervation ( Moore and Bloom, 1979; Gottesfeld, 1983; Unnerstall et al., 1984; Berridge et al., 1997; Delfs et al., 1998; Lecourtier and Kelly, 2007) . To test whether the effect of methylphenidate on social play depended on noradrenergic neurotransmission, we next infused atomoxetine into brain regions in which methylphenidate was found to inhibit social play behavior.
Materials and Methods
Animals. Male Wistar rats (Charles River) arrived in our animal facility on postnatal day (P) 21. They were housed in groups of four in 40 ϫ 26 ϫ 20 (l ϫ w ϫ h) cm Macrolon cages under controlled conditions (i.e., temperature 20 -21°C, 55-65% relative humidity, and 12/12 h light cycle with lights on at 7:00 A.M.). Food and water were available ad libitum. During the first 6 d after arrival, the rats were handled at least twice. All experiments were approved by the Animal Ethics Committee of Utrecht University and were conducted in accordance with Dutch legislation (Wet op de Dierproeven, 1996) and European regulations (Guideline 86/609/EEC).
Surgical procedures. The surgical procedures were based on previous experiments (Trezza et al., 2011a; van Kerkhof et al., 2013a van Kerkhof et al., , 2013b . On P26 -P27, the rats were anesthetized subcutaneously with 0.08 ml/100 g Hypnorm (fentanylcitrate 0.315 mg/ml and fluanison 10 mg/ml; Janssen) and positioned into a stereotactic frame (David Kopf Instruments). Guide cannulae (24 gauge microblasted thin-walled stainless steel; Cooper's Needleworks) were implanted bilaterally. The cannulae were aimed 0.5 mm above the anterior cingulate cortex [coordinates: anterior-posterior (AP) ϩ2.6 mm from bregma; medial-lateral (ML) Ϯ 0.8 mm from the midline; dorsal-ventral (DV) Ϫ2.4 mm from skull surface], prelimbic cortex (coordinates: AP ϩ2.6 mm; ML Ϯ 0.8 mm; DV Ϫ3.2 mm), infralimbic cortex (coordinates: AP ϩ2.6 mm; ML Ϯ 0.8 mm; DV Ϫ4.1 mm), medial/ventral orbitofrontal cortex (coordinates: AP ϩ3.3 mm; ML Ϯ 0.8 mm; DV Ϫ5.3 mm), ventrolateral orbitofrontal cortex (coordinates: AP ϩ3.3 mm; ML Ϯ 1.9 mm; DV Ϫ4.2 mm), mediodorsal thalamus (coordinates: AP Ϫ2.4 mm; ML Ϯ 0.8 mm; DV Ϫ5.3 mm), habenula (coordinates: AP Ϫ3.0 mm; ML Ϯ 0.8 mm; DV Ϫ4.7 mm), 1.0 mm above the nucleus accumbens shell (coordinates: AP ϩ1.5 mm; ML Ϯ 0.8 mm; DV Ϫ5.3 mm), or BLA (coordinates: AP Ϫ1.9 mm; ML Ϯ 4.4 mm; DV Ϫ7.8 mm). Coordinates were based on previous experiments (Trezza et al., 2011a van Kerkhof et al., 2013a van Kerkhof et al., , 2013b or determined by pilot placements in 28-d-old rats. Cannulae were secured with stainless steel screws and dental acrylic. Stainless steel stylets (29 gauge) were inserted into the guide cannulae to maintain patency. After surgery, rats were individually housed for 4 d to recover, after which they were housed with their original cage mates.
Drugs and infusion procedures. Methylphenidate-HCl (5.0 g/0.3 l; Sigma) was dissolved in saline; vehicle infusions contained saline only. Atomoxetine-HCl (10.0 g/0.3 l; Tocris Bioscience) was dissolved in 50% dimethylsulfoxide (DMSO)/50% saline; vehicle infusions consisted of 50% DMSO/50% saline. The potential neurotoxicity of DMSO may be a point of concern when using it as an injection vehicle. Neurotoxic effects of DMSO have been reported after 10 systemic injections (Cavaletti et al., 2000) ; however, this treatment schedule had only marginal effects on behavior (Authier et al., 2002) . In our studies, DMSO was given for a maximum of three times in a small amount and volume. Furthermore, our histological analysis did not reveal any sign of tissue damage in rats infused with DMSO. Because we found no major differences in behavior between animals that received infusions with saline (the vehicle for methylphenidate) or DMSO (the vehicle for atomoxetine), we consider it unlikely that neurotoxic effects of DMSO have influenced the data. Drug doses were based on previous studies (Zheng et al., 2008; Tye et al., 2010) and pilot experiments. Infusion procedures were as described previously (Trezza et al., 2011a van Kerkhof et al., 2013a van Kerkhof et al., , 2013b . In short, bilateral infusions were administered using 30-gauge injection needles (Bilaney) that were connected to 10 l Hamilton microsyringes by polyethylene (PE-20) tubing. Over 60 s, 0.3 l of drug or vehicle solution was infused using a syringe pump (model 975A; Harvard Apparatus) and the injectors were left in place for another 60 s to allow for diffusion. After the procedure, stylets were replaced and animals were left in a holding cage for 5 min before testing.
Behavioral testing. Experiments were performed as described previously ( Vanderschuren et al., 2008) in a sound-attenuated chamber under red light conditions. The testing arena was a Plexiglas cage (40 ϫ 40 ϫ 60 cm; l ϫ w ϫ h) with ϳ2 cm of wood shavings covering the floor. Animals were paired with an unfamiliar partner (i.e., not a cage mate). Animals in a test pair did not differ Ͼ10 g in body weight. Animals arrived in the facility at P21 and underwent surgery on P26 or P27. After surgery, the rats were habituated to the experimental procedures on 2 consecutive days. On the first habituation day (P32), rats were individually placed into the test cage for 10 min. On the second habituation day (P33), the animals were socially isolated for 2.5 h. Pairs of rats were then infused with vehicle solutions and placed into the test cage for 15 min to habituate them to the infusion and testing procedures. On the third day (P34), which was the first test day, rats were isolated for 2.5 h. Both rats in a pair were then simultaneously infused with either drug (methylphenidate or atomoxetine) or vehicle before testing. On the second test day (P36), the animals were also isolated for 2.5 h and treatments were reversed so that animals that received drug (methylphenidate or atomoxetine) treatment on the first test day now received vehicle and vice versa. The first and second test day were separated by a wash-out day (P35) during which the animals received no treatment and were not tested. Therefore, the effects of methylphenidate and atomoxetine on social play behavior were investigated using a within-subjects design except for the experiment in which methylphenidate was infused into the BLA. Because of technical issues, in this experiment, two independent groups of animals received either vehicle or methylphenidate and were tested once.
In the first set of experiments, we determined the brain regions in which methylphenidate affected social play behavior by infusing it into the anterior cingulate cortex, prelimbic cortex, infralimbic cortex, medial/ventral orbitofrontal cortex, ventrolateral orbitofrontal cortex, mediodorsal thalamus, habenula, nucleus accumbens shell, or BLA. We have previously found that the effect of methylphenidate on social play behavior relies on noradrenergic neurotransmission . Therefore, in the second, independent set of experiments, we tested the hypothesis that intracranial administration of methylphenidate inhibits social play behavior through a noradrenergic mechanism of action by infusing atomoxetine into the brain regions in which we found methylphenidate to reduce social play behavior.
Testing consisted of placing a pair of animals into the arena for 15 min. Behavior of the animals was recorded using a camera with zoom lens, video tape recorder, and television monitor. The behavior of the rats was assessed using Observer 5.1 software (Noldus Information Technology). The structure of social play behavior in rats has been described previously in detail ( Bolles and Woods, 1964; Baenninger, 1967; Poole and Fish, 1975; Panksepp and Beatty, 1980; Pellis and Pellis, 1987; Pellis et al., 1989 , for reviews see Panksepp et al., 1984; Pellis and Pellis, 1998; Trezza et al., 2010) . In rats, a bout of social play behavior starts with one rat soliciting ("pouncing") another animal by attempting to nose or rub the nape of its neck. The animal that is pounced upon can respond in different ways. If the animal that is pounced upon responds by evading, the soliciting rat may start to chase it, thus making another attempt to launch a play bout. The solicited animal may also rear toward the soliciting animal and the two animals may rapidly push, paw, and grab each other ("boxing"). If the animal that is pounced upon fully rotates to its dorsal surface, "pinning" is the result, meaning one animal lying with its dorsal surface on the floor with the other animal standing over it. From this position, the supine animal can initiate another play bout by trying to gain access to the other animal's neck. Therefore, during social play, pouncing is considered an index of play solicitation and pinning can be regarded as the terminal component of a single play bout as well as a releaser of a prolonged play bout (Poole and Fish, 1975; Panksepp and Beatty, 1980; Pellis and Pellis, 1987; Pellis et al., 1989) . Pinning and pouncing frequencies can be easily quantified and are considered the most characteristic parameters of social play behavior in rats ( Panksepp and Beatty, 1980) . Pinning and pouncing usually occur very rapidly and are of short duration. Therefore, scoring their frequency is more informative than scoring their duration. We have also found that pinning and pouncing are very reliable play parameters that occur consistently and with considerable frequency during playful encounters (see also Panksepp and Beatty, 1980; Vanderschuren et al., 1995) , whereas the occurrence of chasing and boxing is quite variable between pairs of animals and experiments. During the tests for social play, the rats also display social behaviors not directly associated with play, such as sniffing or grooming the partner's body ( Panksepp and Beatty, 1980; Vanderschuren et al., 1995) . Because social play behavior in a rat strongly depends on the playfulness of its partner (Pellis and McKenna, 1992; , in the present study, both animals in a play pair received the same treatment and a pair of animals was considered as one experimental unit. The following parameters were therefore scored per pair of animals: (1) social behaviors related to play: frequency of pinning and frequency of pouncing; and (2) social behaviors unrelated to play: duration of social exploration: the amount of time spent in nonplayful social interaction (i.e., sniffing or grooming).
To assess whether their effects on social play were related to changes in general activity, the effects of methylphenidate and atomoxetine on horizontal locomotor activity were tested on P37 as described previously (Trezza et al., 2009a; Veeneman et al., 2011) . In these experiments, a between-subjects design was used, so that the animals received infusions with methylphenidate, atomoxetine, or vehicle. The infusion protocol was similar to the one described above. After the infusion procedure, rats were transferred to a plastic cage (50 ϫ 33 ϫ 40 cm, l ϫ w ϫ h) and their position was tracked 5 times per second for 30 min using a video-tracking system (EthoVision, Noldus Information Technology).
Histological confirmation of injection sites. Immediately after the locomotor activity test, the animals were killed using carbon dioxide inhalation and microinjected with 0.3 l of black ink over 1 min through the guide cannulae, comparable to the drug infusion procedure. After the infusion, animals were immediately decapitated and their brains removed and immediately frozen. Cryostat sections (20 m) were collected and stained with cresyl violet. Placement of the microinjection sides was determined using a light microscope according to the atlas of Paxinos and Watson (2007) . Only pairs in which both animals had bilateral needle tracks terminating into the target area were included in the final analysis of social play behavior (Figs. 1, 2) . As mentioned above, the effects of methylphenidate and atomoxetine on horizontal locomotor activity was assessed per individual animal using a between-subjects design. Therefore, each animal with correct cannula placements was included in the analysis of locomotor activity even if it was not used for the analysis of social play behavior because its partner had incorrect placements (and the pair was therefore excluded).
Statistical analysis. Pinning and pouncing frequencies and time spent on social exploration (in seconds) were scored per pair of animals and expressed as mean ϩ SEM. To assess the effect of methylphenidate and atomoxetine administration on social play behavior, data were analyzed using a paired-samples Student's t test. In the experiment in which methylphenidate was administered into the BLA, data were analyzed using an independent Student's t test. Horizontal locomotor activity was assessed per individual animal and expressed as mean Ϯ SEM traveled distance (in centimeters) in 5 min bins. The effects of methylphenidate and atomoxetine on locomotor activity were analyzed using a one-way repeated-measures ANOVA.
Results
Methylphenidate infusion into medial prefrontal but not orbitofrontal cortical regions inhibits social play Infusion of methylphenidate into the anterior cingulate cortex reduced pinning (t (6) ϭ 3.10, p ϭ 0.02) and pouncing (t (6) ϭ 2.49, p ϭ 0.05) and tended to increase social exploration (t (6) ϭϪ2.24, p ϭ 0.07) (Fig. 3A-C,nϭ7) . No effect on locomotor activity was found (F treatment(1,14) ϭ 0.43, p ϭ 0.78; F time(5,70) ϭ 19.11, p Ͻ 0.001; F time ϫ treatment(5,70) ϭ 0.49, p ϭ 0.78, n ϭ 8) (Fig. 3D) . After infusion of methylphenidate into the infralimbic cortex (social play behavior: n ϭ 12; locomotor activity: vehicle n ϭ 7, methylphenidate n ϭ 9), a reduction in pinning (t (11) ϭ 2.46, p ϭ 0.03) and pouncing (t (11) ϭ 2.47, p ϭ 0.03) (Fig. 4A,B) but not social exploration (t (11) ϭ Ϫ1.16, p ϭ 0.13) or locomotor activity (F treatment(1,14) ϭ 0.43, p ϭ 0.78; F time(5,70) ϭ 16.05, p Ͻ 0.001; F time ϫ treatment(5,70) ϭ 0.44, p ϭ 0.84) (Fig. 4C,D) was found.
Treatment with methylphenidate in the prelimbic cortex, the medial/ventral orbitofrontal cortex, and ventrolateral orbitofrontal cortex did not affect social play or social exploratory behavior (Table 1) .
Methylphenidate infusion into the BLA and habenula, but not nucleus accumbens shell or mediodorsal thalamus, reduces social play Infusion of methylphenidate into the BLA (n ϭ 6) reduced the frequency of pinning (t (10) ϭ 2.73, p ϭ 0.02) and pouncing (t (10) ϭ 2.82, p ϭ 0.02) without changing social exploration (t (10) ϭ 0.86, p ϭ 0.41) or locomotor activity (F treatment(1,17) ϭ 0.22, p ϭ 0.65; F time(5,85) ϭ 26.48, p Ͻ 0.001; F time ϫ treatment(5,85) ϭ 0.75, p ϭ 0.59; Fig. 5A-D) .
A reduction in the frequency of both play parameters was also observed after administration of methylphenidate into the habenula (n ϭ 9) (pinning: t (8) ϭ 4.87, p ϭ 0.001; pouncing: t (8) ϭ 5.58, p ϭ 0.001) (Fig. 6 A, B) . No changes were observed in the time spent on social exploration (t (8) ϭϪ0.19, p ϭ 0.85) or in locomotor activity (F treatment(1,18) Administration of methylphenidate into the nucleus accumbens shell or the mediodorsal thalamus did not affect social play behavior or social exploration (Table 1) .
Atomoxetine infusion into the anterior cingulate cortex, infralimbic cortex, BLA, and habenula decreases social play Infusion of atomoxetine into the anterior cingulate cortex (social play behavior: n ϭ 8; locomotor activity: vehicle n ϭ 8, atomoxetine n ϭ 11) reduced pinning (t (7) ϭ 7.68, p Ͻ 0.001) and pouncing (t (7) ϭ 7.74, p Ͻ 0.001) and increased the time spent on social exploration (t (7) ϭϪ3.84, p ϭ 0.01) (Fig. 3A-C) . However, no effect on locomotor activity was found (F treatment(1,17) ϭ Figure 3 . The effect of methylphenidate (mph; 5.0 g/0.3 l, gray bar; social play behavior, n ϭ 7; locomotor activity, n ϭ 8) or atomoxetine (ato; 10.0 g/0.3 l, black bar; social play behavior, n ϭ 8; locomotor activity: vehicle, n ϭ 8; atomoxetine, n ϭ 11) administration into the anterior cingulate cortex. Data are presented as mean ϩ SEM. Both methylphenidate and atomoxetine reduced pinning (A) and pouncing (B) after infusion into the anterior cingulate cortex. Methylphenidate tended to increase and atomoxetine increased social exploration (C), but neither drug affected locomotor activity (D,E). *p Յ 0.05, **p Յ 0.01, ***p Ͻ 0.001, #p ϭ 0.07, paired t test. 3 l, gray bar; social play behavior, n ϭ 12; locomotor activity: vehicle, n ϭ 7; methylphenidate, n ϭ 9) or atomoxetine (ato; 10.0 g/0.3 l, black bar; social play behavior, n ϭ 10; locomotor activity: vehicle, n ϭ 12; atomoxetine, n ϭ 9) administration into the infralimbic cortex on social play behavior. Data are presented as mean ϩ SEM. Both methylphenidate and atomoxetine infusion into the infralimbic cortex decreased pinning (A) and pouncing (B). Methylphenidate did not affect and atomoxetine increase social exploration (C). Neither methylphenidate nor atomoxetine infusion into the infralimbic cortex affected locomotor activity (D, E). *p Յ 0.05, **p Յ 0.01, paired t test. (Fig. 3E) .
Treatment with atomoxetine in the infralimbic cortex (social play behavior: n ϭ 10; locomotor activity: vehicle n ϭ 12, atomoxetine n ϭ 9) reduced pinning (t (9) ϭ 2.91, p ϭ 0.02) and pouncing (t (9) ϭ 3.55, p ϭ 0.01) and increased social exploration (t (9) ϭϪ2.27, p ϭ 0.05) (Fig. 4A-C) . Intra-infralimbic cortex atomoxetine did not alter locomotor activity (F treatment(1,19) ϭ 0.14, p ϭ 0.71; F time(5,95) ϭ 26.78, p Ͻ 0.001; F time ϫ treatment(5,95) ϭ 0.44, p ϭ 0.82; Fig. 4E ).
After infusion of atomoxetine into the BLA (social play behavior: n ϭ 6; locomotor activity: vehicle n ϭ 9, atomoxetine n ϭ 7), a reduction in pinning (t (5) ϭ 3.34, p ϭ 0.02) and pouncing (t (5) ϭ 3.38, p ϭ 0.02) (Fig. 5A,B) was found. Intra-BLA atomoxetine did not affect social exploration (t (5) ϭ Ϫ1.78, p ϭ 0.14; Fig. 5C ) or locomotor activity (F treatment(1,14) ϭ 0.89, p ϭ 0.36; F time(5,70) ϭ 19.64, p Ͻ 0.001; F time ϫ treatment(5,70) ϭ 1.95, p ϭ 0.10; Fig. 5E ).
When atomoxetine was infused into the habenula (social play behavior: n ϭ 7; locomotor activity: n ϭ 8), pinning (t (6) ϭ 2.39, p ϭ 0.05) and pouncing (t (6) ϭ 3.53, p ϭ 0.02) (Fig. 6 A, B) were reduced, whereas social exploration (t (6) 
Discussion
Infusion of methylphenidate and atomoxetine into the anterior cingulate and infralimbic cortex, BLA and habenula inhibited social play behavior in rats. These effects were behaviorally specific because methylphenidate and atomoxetine did not inhibit social exploratory behavior or locomotor activity. Moreover, these effects were anatomically specific because infusion of methylphenidate into the prelimbic, medial/ventral orbitofrontal and ventrolateral orbitofrontal cortex, nucleus accumbens shell, and mediodorsal thalamus did not alter social play behavior.
Prefrontal mechanisms underlying the inhibition of social play behavior by methylphenidate
Methylphenidate and atomoxetine reduced social play behavior after administration into the anterior cingulate and infralimbic cortex. The prefrontal cortex is thought to mediate higher cognitive functions such as attention, planning, cognitive flexibility, and decision making (Miller and Cohen, 2001; Dalley et al., 2004; Robbins and Arnsten, 2009; Schoenbaum et al., 2009) . Because social interactions are inherently complex and unpredictable, it is likely that frontal cortical regions subserve executive functions in social situations (Adolphs, 2003; Blakemore, 2008; Rilling et al., 2008) , including social play behavior ( Siviy and Panksepp, 2011; Vanderschuren and Trezza, 2014) .
We have previously hypothesized that methylphenidate reduces social play by improving behavioral inhibition, that is, by suppressing a vigorous form of social behavior that is associated with diminished attention for the environment . Indeed, systemic methylphenidate and atomoxetine are known to improve behavioral inhibition in rats and humans, Figure 5 . The effect of methylphenidate (mph; 5.0 g/0.3 l, gray bar; social play behavior, n ϭ 6; locomotor activity: n ϭ 6) or atomoxetine (ato; 10.0 g/0.3 l, black bar; social play behavior, n ϭ 6; locomotor activity: vehicle, n ϭ 9; atomoxetine, n ϭ 7) administration into the BLA on social play behavior. Data are presented as mean ϩ SEM. Both methylphenidate and atomoxetine reduced pinning (A) and pouncing (B), but did not affect social exploration (C) or locomotor activity (D,E). *p Ͻ 0.05, independent (mph) or paired (ato) t test. in paradigms such as the stop signal task (SST) and the 5-choice serial reaction time task (5-CSRTT) ( Chamberlain and Sahakian, 2007; Eagle et al., 2008; Pattij and Vanderschuren, 2008) . However, it has been reported recently that atomoxetine increases SST performance via the dorsal prelimbic and (ventrolateral) orbitofrontal, but not anterior cingulate or infralimbic cortex (Bari et al., 2011) . Moreover, infusion of atomoxetine into the infralimbic cortex did not affect premature responding in the 5-CSRTT (Economidou et al., 2012) . Therefore, if methylphenidate and atomoxetine reduce social play through enhanced or exaggerated inhibition of behavior, then this aspect of inhibition is probably distinct from the constructs analyzed in the SST and 5-CSRTT. Alternatively, the prefrontally mediated inhibition of social play by methylphenidate and atomoxetine may be related to impaired behavioral flexibility. Thus, depletion of noradrenaline from the ventromedial prefrontal cortex, including the infralimbic cortex (McGaughy et al., 2008) or the medial prefrontal cortex, including both the anterior cingulate and prelimbic cortex (Tait et al., 2007) , disrupted extradimensional shifting in an attentional set-shifting task. Remarkably, although atomoxetine reversed the set-shifting deficit produced by noradrenergic depletion, it disrupted performance in sham-lesioned rats (Newman et al., 2008) . In the context of social play, this suggests that noradrenergic mechanisms in the prefrontal cortex subserve the cognitive flexibility necessary to be able to respond to the changeable, often unpredictable behavior of a conspecific. The finding that atomoxetine infusion into the anterior cingulate and infralimbic cortex mimicked the effect of methylphenidate on social play is consistent with a noradrenergic mechanism of action of methylphenidate. Methylphenidate blocks the reuptake of both dopamine and noradrenaline (Ferris and Tang, 1979; Ritz et al., 1987) and reuptake of dopamine in the prefrontal cortex mainly occurs through the noradrenaline transporter (Tanda et al., 1997; Yamamoto and Novotney, 1998; Moró n et al., 2002) . Therefore, intra-prefrontal blockade of the noradrenaline transporter also increases prefrontal dopamine neurotransmission. However, our previous findings that the effects of methylphenidate and amphetamine on social play behavior were not influenced by pretreatment with a dopamine receptor antagonist indicate that enhanced prefrontal dopamine neurotransmission does not underlie the play-suppressant effects of methylphenidate and atomoxetine.
We have reported previously that functional inactivation of medial prefrontal subregions, i.e., the prelimbic, infralimbic, and medial/ventral orbitofrontal cortex, inhibits social play (van Kerkhof et al., 2013a) . Interestingly, of these regions, only the infralimbic cortex was involved in the play-reducing effects of methylphenidate and atomoxetine. Together, these findings provide a view into the heterogeneity of the prefrontal functions involved in social play (Pellis et al., 2006; Bell et al., 2009) Limbic subcortical mechanisms underlying the inhibition of social play behavior by methylphenidate Methylphenidate and atomoxetine infusion into the BLA and the habenula, but not the nucleus accumbens shell or mediodorsal thalamus, suppressed social play behavior. Noradrenaline has been shown to reduce neuronal activity in the BLA via ␣2-adrenoceptors (Ferry et al., 1997; Buffalari and Grace, 2007; Johnson et al., 2011) . Because stimulation of ␣2-adrenoceptors underlies the play-suppressant effect of methylphenidate , the inhibition of social play by methylphenidate and atomoxetine may be the result of reduced BLA output. This is consistent with previous findings that amygdala lesions reduce social play in male rats (Meaney et al., 1981; Daenen et al., 2002) . In addition, systemic treatment with low doses of methylphenidate has been reported to decrease glucose metabolism in the habenula (Porrino and Lucignani, 1987) , suggesting that enhancement of noradrenergic neurotransmission by methylphenidate and atomoxetine results in decreased habenula activity. Indeed, we have shown recently that functional inactivation of the habenula decreased social play behavior (van Kerkhof et al., 2013b) .
Social play is a highly rewarding activity (Vanderschuren, 2010; Trezza et al., 2011b) and both the BLA and habenula are involved in reward processes (Baxter and Murray, 2002; Cardinal et al., 2002; Lecourtier and Kelly, 2007; Hikosaka, 2010; Morrison and Salzman, 2010) . Indeed, we have found recently that endocannabinoid-mediated facilitation of social play, which may be related to increased reward value, occurs within the BLA . Therefore, functional inhibition of the BLA and habenula by methylphenidate and atomoxetine may have reduced the positive emotional properties of social play. Alternatively, methylphenidate and atomoxetine in the BLA and habenula may have influenced cognitive aspects of social play, perhaps in concert with prefrontal regions (Pitkänen, 2000; Sah Figure 6 . The effect of methylphenidate (mph; 5.0 g/0.3 l, gray bar; social play behavior, n ϭ 9; locomotor activity: n ϭ 9) or atomoxetine (ato; 10.0 g/0.3 l, black bar; social play behavior, n ϭ 7; locomotor activity: n ϭ 8) administration into the habenula on social play behavior. Data are presented as mean ϩ SEM. Both methylphenidate and atomoxetine infusion into the habenula decreased pinning (A) and pouncing (B), but not social exploration (C) or locomotor activity (D, E). *p Յ 0.05, ***p Յ 0.001, paired t test.
et al., 2003; Lecourtier and Kelly, 2007) . For example, habenula lesions have been shown to disrupt attention ( Lecourtier and Kelly, 2005) and the BLA has been implicated in behavioral flexibility (Schoenbaum et al., 2003; Churchwell et al., 2009) . Last, both the habenula and BLA are involved in stress-and anxietyrelated behaviors (Phelps and LeDoux, 2005; Roozendaal et al., 2009; Hikosaka, 2010; Shin and Liberzon, 2010 ), but we consider it unlikely that changes in these latter processes explain the effects of methylphenidate and atomoxetine on social play behavior. Thus, intra-BLA and intra-habenula methylphenidate and atomoxetine did not affect social exploratory behavior, which is the standard parameter used in the social interaction test of anxiety (File and Seth, 2003) . Moreover, pharmacological analysis of social play behavior has shown that anxiolytic or anxiogenic drugs do not invariably increase or reduce social play, respectively Trezza et al., 2009a) .
Neurocircuitry of social play behavior
Importantly, our present data show that the suppression of social play behavior by methylphenidate and atomoxetine is not exerted through a single brain region. Rather, methylphenidate and atomoxetine act in a distributed network of brain regions, likely affecting different emotional and cognitive aspects of social play behavior at the same time, which results in a profound inhibition of this behavior . The infralimbic cortex, anterior cingulate cortex, BLA, and habenula may therefore be part of an interconnected functional network involved in the modulation of social play behavior. Indeed, these four regions have reciprocal connections with the locus ceruleus ( Moore and Bloom, 1979; Gottesfeld, 1983; Unnerstall et al., 1984; Jodo et al., 1998; Pitkänen, 2000; Vertes, 2004; Hoover and Vertes, 2007; Lecourtier and Kelly, 2007; Radley et al., 2008) . Furthermore, the intralimbic cortex has reciprocal connections with the anterior cingulate cortex and both have reciprocal connections with the BLA (Pitkänen, 2000; Vertes, 2004; Hoover and Vertes, 2007) . The infralimbic cortex also sends a moderate innervation to the habenula. Last, both the BLA and habenula send distributed outputs to the thalamus, which in turn innervates the prefrontal cortex (Groenewegen, 1988; De Olmos et al., 2004; Lecourtier and Kelly, 2007) . Therefore, the four structures implicated in the effects of methylphenidate and atomoxetine on social play are intricately linked.
The social play parameters analyzed in the present study, pinning and pouncing, are the most characteristic behaviors observed during social play behavior in rats ( Panksepp and Beatty, 1980) . The present study suggests that these behaviors can be modulated by altering the underlying cognitive and emotional processes in social play, resulting in what may appear to be uniform reductions in social play. Clearly, even though manipulating noradrenergic transmission in prefrontal and subcortical limbic structures can have similar consequences for pinning and pouncing, the underlying cognitive and emotional processes are likely to be different. Therefore, future studies using place conditioning and operant conditioning can reveal whether these reductions in play behavior are the result of changes in the rewarding (Trezza et al., 2009b) , cognitive , or motivational properties (van Kerkhof et al., 2012) of social play.
Conclusion
This study provides new insights into the neural underpinnings of a developmentally important social activity, as well as the behavioral mechanism of action of two drugs widely used for the treatment of ADHD. Our findings suggest that an interplay between limbic cortical and subcortical structures underlies the integration of cognitive and emotional information during the proper execution of a playful social encounter.
